Clan Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 04-12-2024
- Paid Up Capital ₹ 2.10 M
as on 04-12-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.66 Cr
as on 04-12-2024
- Satisfied Charges ₹ 6.00 M
as on 04-12-2024
- Revenue 12.95%
(FY 2022)
- Profit -41.98%
(FY 2022)
- Ebitda 27.27%
(FY 2022)
- Net Worth 2.80%
(FY 2022)
- Total Assets 25.83%
(FY 2022)
About Clan Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹1.66 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Vishnu Mishra, Rajendra Bisht, and Deepak Bhatia serve as directors at the Company.
- CIN/LLPIN
U24232UP2005PTC030875
- Company No.
030875
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Clan Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnu Mishra  | Director | 24-Oct-2005 | Current |
| Rajendra Bisht | Director | 24-Oct-2005 | Current |
| Deepak Bhatia | Director | 04-Feb-2015 | Current |
Financial Performance of Clan Pharma.
Clan Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.95% increase. The company also saw a substantial fall in profitability, with a 41.98% decrease in profit. The company's net worth moved up by a moderate rise of 2.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clan Pharma?
In 2022, Clan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Bajrang Land Developers Private LimitedActive 13 years 5 monthsVishnu Mishra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2022 | ₹1.00 M | Open |
Others Creation Date: 14 Jan 2020 | ₹0.80 M | Open |
Others Creation Date: 29 Mar 2019 | ₹1.48 Cr | Open |
How Many Employees Work at Clan Pharma?
Unlock and access historical data on people associated with Clan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
